Lucentis (ranibizumab) - Roche, Novartis
Novel laboratory technique for immunofluorescent detection of intraocular ranibizumab in a rat model. (PubMed, Exp Eye Res) - Oct 8, 2026 - "This method, including the sequence incubation change, made it possible to accurately identify ranibizumab molecules alone by using the specific anti-Fab together with anti-IgG antibodies. This technique may enhance further research involving the demonstration of ranibizumab in an animal model." 
Journal • Preclinical
http://www.ncbi.nlm.nih.gov/pubmed/42843501
 
Assaf Ben-Arzi; Assaf Dotan; Irit Bahar; Itay Spector; Orly Gal-Or; Yariv Keshet
 
Oct 8, 2026
 
Prev Next